Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126846591 | 12684659 | 1 | I | 20160818 | 20160825 | 20160825 | EXP | PHHY2016JP113742 | SANDOZ | NISHIHAMA K, MAKI K, OKANO Y, HASHIMOTO R, HOTTA Y, UEMURA M. A CASE OF TYPE 2 DIABETES MELLITUS WITH METFORMIN-ASSOCIATED LACTIC ACIDOSIS INITIALLY PRESENTING THE APPEARANCE OF A SULFONYLUREA-RELATED HYPOGLYCEMIC ATTACK. ACUTE MEDICINE AND SURGERY. ACUTE MEDICINE AND SURGERY. 2016 | 64.00 | YR | F | Y | 77.20000 | KG | 20160825 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126846591 | 12684659 | 1 | PS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 2250 MG, QD | U | 75985 | 2250 | MG | QD | ||||||
| 126846591 | 12684659 | 2 | SS | OLMESARTAN | OLMESARTAN | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 126846591 | 12684659 | 3 | SS | CANDESARTAN CILEXETIL. | CANDESARTAN CILEXETIL | 1 | Unknown | 8 MG, QD | U | 0 | 8 | MG | QD | ||||||
| 126846591 | 12684659 | 4 | C | TOCOPHEROL | TOCOPHEROL | 1 | Unknown | 600 MG, QD | U | 0 | 600 | MG | QD | ||||||
| 126846591 | 12684659 | 5 | C | GLIMEPIRID | GLIMEPIRIDE | 1 | Unknown | 1 MG, QD | U | 0 | 1 | MG | QD | ||||||
| 126846591 | 12684659 | 6 | C | VOGLIBOSE | VOGLIBOSE | 1 | Unknown | 0.9 MG, QD | U | 0 | .9 | MG | QD | ||||||
| 126846591 | 12684659 | 7 | C | EXENATIDE | EXENATIDE | 1 | Unknown | 20 IG, , QD | U | 0 | QD | ||||||||
| 126846591 | 12684659 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
| 126846591 | 12684659 | 9 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | Unknown | 2.5 MG, QD | U | 0 | 2.5 | MG | QD | ||||||
| 126846591 | 12684659 | 10 | C | POLAPREZINC | POLAPREZINC | 1 | Unknown | 150 MG, QD | U | 0 | 150 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126846591 | 12684659 | 1 | Type 2 diabetes mellitus |
| 126846591 | 12684659 | 2 | Hypertension |
| 126846591 | 12684659 | 3 | Hypertension |
| 126846591 | 12684659 | 4 | Hypertension |
| 126846591 | 12684659 | 5 | Type 2 diabetes mellitus |
| 126846591 | 12684659 | 6 | Product used for unknown indication |
| 126846591 | 12684659 | 7 | Product used for unknown indication |
| 126846591 | 12684659 | 8 | Hypertension |
| 126846591 | 12684659 | 9 | Dyslipidaemia |
| 126846591 | 12684659 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126846591 | 12684659 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126846591 | 12684659 | Acid base balance abnormal | |
| 126846591 | 12684659 | Anorectal disorder | |
| 126846591 | 12684659 | Escherichia urinary tract infection | |
| 126846591 | 12684659 | Fatigue | |
| 126846591 | 12684659 | Hypoglycaemia | |
| 126846591 | 12684659 | Lactic acidosis | |
| 126846591 | 12684659 | Oedema peripheral | |
| 126846591 | 12684659 | Pyrexia | |
| 126846591 | 12684659 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |